ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,163Medicare Part D Prescriptions Filled, Including Refills

Rank: 78 out of 680

$921K Total Retail Price of All Prescriptions

Rank: 99 out of 680

796 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 796 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

20% of this provider’s 796 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 15,387 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 620 536 1 2
METOPROLOL SUCCINATE 539 499 2 13
SIMVASTATIN 516 465 3 3
HYDROCODONE-ACETAMINOPHEN 503 421 S3 4 4
AMLODIPINE BESYLATE 474 433 5 1
METFORMIN HCL 444 396 6 8
FUROSEMIDE 403 386 7 6
PRAVASTATIN SODIUM 403 387 7 10
OMEPRAZOLE 365 321 9 7
LOSARTAN POTASSIUM 317 275 10 21
CRESTOR 295 274 11 25
ZOLPIDEM TARTRATE 271 218 12 17
LOSARTAN-HYDROCHLOROTHIAZIDE 254 237 13 51
HYDROCHLOROTHIAZIDE 253 236 14 9
BENAZEPRIL HCL 241 222 15 40
NEXIUM 230 184 16 16
CLOPIDOGREL 220 194 17 26
GABAPENTIN 196 176 18 15
ATORVASTATIN CALCIUM 194 186 19 11
PANTOPRAZOLE SODIUM 191 146 20 30
FENOFIBRATE 188 146 21 66
NIFEDIPINE ER 187 182 22 75
ESCITALOPRAM OXALATE 172 160 23 45
WARFARIN SODIUM 166 146 24 20
SYNTHROID 162 162 25 38
MELOXICAM 161 138 26 24
LISINOPRIL 160 151 27 5
METOPROLOL TARTRATE 154 113 28 12
ISOSORBIDE MONONITRATE ER 152 147 29 59
TAMSULOSIN HCL 149 124 30 34
ATENOLOL 147 133 31 19
SERTRALINE HCL 143 124 32 28
CARVEDILOL 139 134 33 23
PLAVIX 137 122 34 39
FLUTICASONE PROPIONATE 134 129 35 41
METHYLPREDNISOLONE 121 99 36 93
JANUVIA 120 112 37 60
CYMBALTA 119 99 38 46
GLIMEPIRIDE 118 111 39 29
NAMENDA 116 116 40 35
GLIPIZIDE ER 114 113 41 108
AMOX TR-POTASSIUM CLAVULANATE 112 103 42 124
LISINOPRIL-HYDROCHLOROTHIAZIDE 110 105 43 37
DOXYCYCLINE HYCLATE 110 100 43 95
CITALOPRAM HBR 109 108 45 22
AMITRIPTYLINE HCL 107 100 R 46 47
AMLODIPINE BESYLATE-BENAZEPRIL 103 87 47 43
CELEBREX 100 86 48 90
DIOVAN 99 99 49 31
BENAZEPRIL-HYDROCHLOROTHIAZIDE 92 86 50 164
ALENDRONATE SODIUM 91 91 51 32
KLOR-CON M20 89 77 52 61
POTASSIUM CHLORIDE 87 69 53 14
RAMIPRIL 86 52 54 69
TRIAMTERENE-HCTZ 81 81 55 52
LANTUS SOLOSTAR 81 46 55 84
AZITHROMYCIN 79 67 57 42
SPIRIVA 77 74 58 70
PROPRANOLOL HCL 77 67 58 145
QUINAPRIL HCL 74 74 60 104
GLYBURIDE-METFORMIN HCL 72 55 R 61 107
BUPROPION XL 72 67 61 161
ZETIA 72 60 61 87
METFORMIN HCL ER 71 62 64 54
EVISTA 70 60 65 135
POLYETHYLENE GLYCOL 3350 69 64 66 62
ALLOPURINOL 69 69 66 33
AMOXICILLIN 68 48 68 111
GLYBURIDE 67 62 R 69 85
CEFDINIR 63 56 70 212
ATENOLOL-CHLORTHALIDONE 62 56 71 205
LEVOFLOXACIN 61 58 72 97
VYTORIN 61 61 72 152
LANSOPRAZOLE 60 60 74 184
DONEPEZIL HCL 60 60 74 27
TRAZODONE HCL 59 50 76 48
GLIPIZIDE 54 51 77 63
PEN NEEDLE 52 34 78 122
MECLIZINE HCL 52 50 78 103
NIFEDICAL XL 51 32 80 220
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.